As shown in Fig. 3G-I, nab-paclitaxel treatment elicited potent inhibition of tumor growth; however, the growth inhibition caused by nab-paclitaxel was diminished in ZFP64-overexpressing tumors. This evidence concerns the gene ZFP64 and neoplasm.